CyVek Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$97M
- Investors
-
1
CyVek General Information
Description
Developer of a technology platform for measuring analytes in biological samples. The company provides an integrated test system which includes microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples.
Contact Information
Website
www.cyvek.comCorporate Office
- 2 Barnes Industrial Road
- South
- Wallingford, CT 06492
- United States
Corporate Office
- 2 Barnes Industrial Road
- South
- Wallingford, CT 06492
- United States
CyVek Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Nov-2014 | $97M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series D) | 07-Apr-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 30-Jan-2013 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 11-Apr-2012 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 20-May-2010 | $4.01M | $5.96M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 10-Feb-2010 | $1.95M | $1.95M | Completed | Startup |
CyVek Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 3,858,174 | $0.000100 | 8% | $1.04 | $1.04 | 1x | $0.83 | 18.74% |
| Series A | 1,600,000 | $0.000100 | 8% | $0.25 | $0.25 | 1x | $0.25 | 6.24% |
CyVek Patents
CyVek Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013142847-A1 | Pdms membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them | Inactive | 22-Mar-2012 | ||
| US-20140377852-A1 | Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays | Active | 08-Mar-2012 | ||
| WO-2013134740-A1 | Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays | Inactive | 08-Mar-2012 | ||
| WO-2013134741-A2 | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results | Inactive | 08-Mar-2012 | ||
| WO-2013134741-A3 | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results | Inactive | 08-Mar-2012 | G01N1/28 |
CyVek Signals
CyVek Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Connecticut Innovations | Venture Capital | Minority |
CyVek FAQs
-
When was CyVek founded?
CyVek was founded in 2010.
-
Where is CyVek headquartered?
CyVek is headquartered in Wallingford, CT.
-
What is the size of CyVek?
CyVek has 40 total employees.
-
What industry is CyVek in?
CyVek’s primary industry is Discovery Tools (Healthcare).
-
Is CyVek a private or public company?
CyVek is a Private company.
-
What is the current valuation of CyVek?
The current valuation of CyVek is .
-
What is CyVek’s current revenue?
The current revenue for CyVek is .
-
How much funding has CyVek raised over time?
CyVek has raised $29.5M.
-
Who are CyVek’s investors?
Connecticut Innovations has invested in CyVek.
-
When was CyVek acquired?
CyVek was acquired on 03-Nov-2014.
-
Who acquired CyVek?
CyVek was acquired by Bio-Techne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process